[Other] Cancer Cachexia Predicts Benefit of Immunotherapy Plus Chemotherapy inEGFR-mutant NSCLC After TKI Resistance

 Close Closed
doubleone Post time 2026-6-4 06:33:16 | Show all posts |Read mode
Reward20points

journalㄩAnticancer Research

AuthorsㄩHARUKA NAKATANI; HAYATO KAWACHI; TADAAKI YAMADA; NAOKI FURUYA; HISASHI TANAKA; AKIHIRO YOSHIMURA; TOMOHIRO OBA; MAKOTO HIBINO; TAKAHITO FUKUDA; YASUHIRO GOTO; AKIRA NAKAO; SHINSUKE OGUSU; YUTA OKAZAKI; TAISHI HARADA; TAKAYO OTA; KEN MASUBUCHI; KOJI MIKAMI; TAE HATA; KENJI MORIMOTO; KOICHI TAKAYAMA

Published dateㄩ2026-5-

DOIㄩ10.21873/anticanres.18159

PDF linkㄩhttps://syndication.highwire.org ... 73/anticanres.18159

Article linkㄩhttps://doi.org/10.21873/anticanres.18159

Article SourceㄩInternational Institute of Anticancer Research


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list